DETECTION OF A RARE MUTATION IN A NOONAN SYNDROME SUSPECTED PATIENT: A CASE REPORT

  • Boban Dobrevski Institute of Immunobiology and Human Genetics, Faculty of Medicine, “Ss. Cyril and Methodius” University of Skopje, Republic of North Macedonia
  • Elena Sukarova - Angelovska University Clinic for Pediatric Diseases, Skopje, Republic of North Macedonia
  • Meri Kirijas Institute of Immunobiology and Human Genetics, Faculty of Medicine, “Ss. Cyril and Methodius” University of Skopje, Republic of North Macedonia
  • Gorjan Milanovski Institute of Immunobiology and Human Genetics, Faculty of Medicine, “Ss. Cyril and Methodius” University of Skopje, Republic of North Macedonia
  • Teodora Brnjarchevska Blazhevska Institute of Immunobiology and Human Genetics, Faculty of Medicine, “Ss. Cyril and Methodius” University of Skopje, Republic of North Macedonia
  • Frosina Boceska Institute of Immunobiology and Human Genetics, Faculty of Medicine, “Ss. Cyril and Methodius” University of Skopje, Republic of North Macedonia
  • Aleksandar Petlichkovski Institute of Immunobiology and Human Genetics, Faculty of Medicine, “Ss. Cyril and Methodius” University of Skopje, Republic of North Macedonia
Keywords: Noonan syndrome, NGS, Genetic diagnosis

Abstract

Noonan syndrome (NS) is a genetic autosomal dominant condition, caused by mutations in PTPN11 and other genes. The aim of this report is to highlight a finding of a rare mutation in the RAF1 gene in a six-year-old child evaluated for Noonan Syndrome. An Ampliseq Research Panel covering A2ML1, BRAF, CBL, HRAS, KRAS, MAP2K1, MAP2K2, NRAS, PTPN11, RAF1, RIT1, SHOC2, SOS1 and SPRED1 genes was used on the Ion Torrent platform. Out of 54 variants detected, a single nucleotide missense mutation c.483T>G in the RAF1 gene was classified as likely pathogenic, based on a single previous submission to Clinvar. Further investigations may shed light on the possible role of this variant in the pathogenesis of Noonan Syndrome and other RASopathies.

Published
2020-05-29
Section
Articles